Research Articles | Page 3 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A Journey from Blood Cells to Genes and Back Aug 2023 Annual Review of Genomics and Human Genetics paroxysmal nocturnal hemoglobinuria (PNH)
A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes. Jun 2013 PLoS One myelodysplastic syndromes (MDS)
A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes. Jun 2013 PLoS One myelodysplastic syndromes (MDS)
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial. Apr 2013 Haematologica myelodysplastic syndromes (MDS)
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes. Jun 2013 Bone Marrow Transplant myelodysplastic syndromes (MDS)
A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes Oct 2016 Biomed Pharmacother myelodysplastic syndromes (MDS)
A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data Jan 2015 Ann Lab Med paroxysmal nocturnal hemoglobinuria (PNH)
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes Aug 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation myelodysplastic syndromes (MDS)
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes Nov 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation myelodysplastic syndromes (MDS)
A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate 1 Risk Myelodysplastic Syndromes Dec 2014 Clin Cancer Res myelodysplastic syndromes (MDS)
Share with addtoany.com.